Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

about

Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

P2860

Q38674757-50AF540D-04EA-41B7-82B4-6D43A531ADB7 Q55294642-FEB4A3D4-A41A-41F4-A915-D5730234404A

P2860

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

Item

http://www.wikidata.org/entity/Q39051290

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

@en

Stereotactic ablative body radiotherapy

@nl

type

Item

label

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

@en

Stereotactic ablative body radiotherapy

@nl

prefLabel

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

@en

Stereotactic ablative body radiotherapy

@nl

P1476

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

@en

P2093

Aaron M Laine

http://www.w3.org/2001/XMLSchema#string

Neil B Desai

http://www.w3.org/2001/XMLSchema#string

Robert D Timmerman

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 A

Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma.

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors.

P304

20160500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20160500

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1070

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28008774

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5685107

http://www.w3.org/2001/XMLSchema#string

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

about

P2860

P2860

Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932